257 related articles for article (PubMed ID: 17253919)
21. Posaconazole: an oral triazole with an extended spectrum of activity.
Rachwalski EJ; Wieczorkiewicz JT; Scheetz MH
Ann Pharmacother; 2008 Oct; 42(10):1429-38. PubMed ID: 18713852
[TBL] [Abstract][Full Text] [Related]
22. Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant.
Alexander BD; Perfect JR; Daly JS; Restrepo A; Tobón AM; Patino H; Hardalo CJ; Graybill JR
Transplantation; 2008 Sep; 86(6):791-6. PubMed ID: 18813103
[TBL] [Abstract][Full Text] [Related]
23. Forty-one recent cases of invasive zygomycosis from a global clinical registry.
Rüping MJ; Heinz WJ; Kindo AJ; Rickerts V; Lass-Flörl C; Beisel C; Herbrecht R; Roth Y; Silling G; Ullmann AJ; Borchert K; Egerer G; Maertens J; Maschmeyer G; Simon A; Wattad M; Fischer G; Vehreschild JJ; Cornely OA
J Antimicrob Chemother; 2010 Feb; 65(2):296-302. PubMed ID: 20008047
[TBL] [Abstract][Full Text] [Related]
24. Posaconazole mono- or combination therapy for treatment of murine zygomycosis.
Ibrahim AS; Gebremariam T; Schwartz JA; Edwards JE; Spellberg B
Antimicrob Agents Chemother; 2009 Feb; 53(2):772-5. PubMed ID: 18936190
[TBL] [Abstract][Full Text] [Related]
25. Disseminated Rhizopus microsporus infection cured by salvage allogeneic hematopoietic stem cell transplantation, antifungal combination therapy, and surgical resection.
Lebeau O; Van Delden C; Garbino J; Robert J; Lamoth F; Passweg J; Chalandon Y
Transpl Infect Dis; 2010 Jun; 12(3):269-72. PubMed ID: 20163567
[TBL] [Abstract][Full Text] [Related]
26. Liposomal amphotericin B and surgery as successful therapy for pulmonary Lichtheimia corymbifera zygomycosis in a pediatric patient with acute promyelocytic leukemia on antifungal prophylaxis with posaconazole.
Kleinotiene G; Posiunas G; Raistenskis J; Zurauskas E; Stankeviciene S; Daugelaviciene V; Machaczka M
Med Oncol; 2013 Mar; 30(1):433. PubMed ID: 23307250
[TBL] [Abstract][Full Text] [Related]
27. Mucormycosis (zygomycosis) in a heart-kidney transplant recipient: recovery after posaconazole therapy.
Tobón AM; Arango M; Fernández D; Restrepo A
Clin Infect Dis; 2003 Jun; 36(11):1488-91. PubMed ID: 12766845
[TBL] [Abstract][Full Text] [Related]
28. Postrenal transplant renopulmonary zygomycosis with vascular aneurysms responded to surgical treatment and salvage therapy with posaconazole after failure to respond to liposomal amphotericin.
Al Maskari Z; Al Lawatia F
Am J Case Rep; 2012; 13():202-5. PubMed ID: 23569529
[TBL] [Abstract][Full Text] [Related]
29. Posaconazole treatment for Apophysomyces elegans rhino-orbital zygomycosis following trauma for a male with well-controlled diabetes.
Ferguson TD; Schniederjan SD; Dionne-Odom J; Brandt ME; Rinaldi MG; Nolte FS; Langston A; Zimmer SM
J Clin Microbiol; 2007 May; 45(5):1648-51. PubMed ID: 17344359
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous zygomycosis.
Bonifaz A; Vázquez-González D; Tirado-Sánchez A; Ponce-Olivera RM
Clin Dermatol; 2012; 30(4):413-9. PubMed ID: 22682190
[TBL] [Abstract][Full Text] [Related]
31. Successful treatment of pulmonary zygomycosis in two transplant recipients with liposomal amphotericin B and partial surgical resection followed by posaconazole.
Cooke DT; Pagani FD; Kaul DR; Cooke KR; Lau CL; Riddell J
Mycoses; 2010 Mar; 53(2):163-7. PubMed ID: 19207843
[No Abstract] [Full Text] [Related]
32. Posaconazole salvage treatment for invasive fungal infection.
Kim JH; Williams K
Mycopathologia; 2014 Oct; 178(3-4):259-65. PubMed ID: 25103141
[TBL] [Abstract][Full Text] [Related]
33. Hyperbaric oxygen therapy and other adjunctive treatments for zygomycosis.
Tragiannidis A; Groll AH
Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():82-6. PubMed ID: 19754764
[TBL] [Abstract][Full Text] [Related]
34. Posaconazole salvage therapy allows successful allogeneic hematopoietic stem cell transplantation in patients with refractory invasive mold infections.
Mullane K; Toor AA; Kalnicky C; Rodriguez T; Klein J; Stiff P
Transpl Infect Dis; 2007 Jun; 9(2):89-96. PubMed ID: 17461992
[TBL] [Abstract][Full Text] [Related]
35. Reviews of anti-infective agents: posaconazole: a broad-spectrum triazole antifungal agent.
Nagappan V; Deresinski S
Clin Infect Dis; 2007 Dec; 45(12):1610-7. PubMed ID: 18190324
[TBL] [Abstract][Full Text] [Related]
36. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis.
Chamilos G; Lewis RE; Kontoyiannis DP
Clin Infect Dis; 2008 Aug; 47(4):503-9. PubMed ID: 18611163
[TBL] [Abstract][Full Text] [Related]
37. Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole.
Paul S; Marty FM; Colson YL
Ann Thorac Surg; 2006 Jul; 82(1):338-40. PubMed ID: 16798251
[TBL] [Abstract][Full Text] [Related]
38. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
Fera MT; La Camera E; De Sarro A
Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous zygomycosis caused by Saksenaea vasiformis following water-related wound in a 24-year-old immunocompetent woman.
Stewardson AJ; Holmes NE; Ellis DH; Howden BP
Mycoses; 2009 Nov; 52(6):547-9. PubMed ID: 19682315
[TBL] [Abstract][Full Text] [Related]
40. [Fatal zygomycosis caused by Mucor indicus after haplo-identical stem cell transplantation].
Koteda S; Nomura K; Hashiguchi M; Kawaguchi K; Oku E; Osaki K; Nakamura T; Mouri F; Imamura R; Seki R; Nagafuji K; Makimura K; Okamura T
Rinsho Ketsueki; 2013 Mar; 54(3):311-5. PubMed ID: 23676649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
